[Modern programs of treatment and rehabilitation of patients with basaliomas: their pathogenic substantiation and clinical effectiveness].
With the aim of forming modern programs for immunogenetic therapy of epithelial tumors, such as methatypic and basal cell carcinomas, the authors of the article analyze the basics of their immunopathogenesis. Having considered the latest immunotherapy regimens, the authors present their clinical assessment.
Snarskaia
E S
ES
Suchkov
S V
SV
Molochkov
V A
VA
D015703:Antigens, CD / Q000276:immunology; D019496:Cancer Vaccines / Q000627:therapeutic use*; D002280:Basal Cell Carcinoma / Q000276:immunology / Q000473:pathology* / Q000628:therapy*; D018450:Disease Progression; D006684:HLA-DR Antigens / Q000276:immunology; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D012878:Skin Neoplasms / Q000276:immunology / Q000473:pathology* / Q000628:therapy*
D015703:Antigens, CD; D019496:Cancer Vaccines; D006684:HLA-DR Antigens